Longboard Pharmaceuticals, Inc.
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatme…
Biotechnology
US, La Jolla [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Longboard Pharmaceuticals, Inc. has no acquisition track records yet.
M&A Deals · History
Longboard Pharmaceuticals, Inc. has no acquisition track records yet.